沃森生物：持续推进产品海外注册出口并加快海外本地化产业项目建设

Core Viewpoint - Watson Bio (300142) is committed to enhancing communication and collaboration with global health organizations and overseas biopharmaceutical companies in the international market [1] Group 1: International Business Development - The company will adopt diversified cooperation models to continuously promote the registration and export of its products in overseas markets [1] - There is a focus on accelerating the construction of localized industrial projects abroad to create value for the company and its shareholders [1] Group 2: Product Development and Updates - Investors are encouraged to keep an eye on the company's announcements regarding the progress of international business and related product development [1]